Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02827968
Title Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors 3D Medicines (Sichuan) Co., Ltd.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Horizon Oncology Research, INC Lafayette Indiana 47905 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas TX 78229 United States Details
*Shaded cells indicate that there was no data available from for the field